Melatonin and female hormone secretion in postmenopausal overweight women

International Journal of Molecular Sciences

Volumn 16, Issue 1, 2015, Pages 1030-1042

  Walecka Kapica, Ewa ^a   Chojnacki, Jan ^a   Stępień, Agnieszka ^a   Wachowska Kelly, Patrycja ^a   Klupińska, Grażyna ^a   Chojnacki, Cezary ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

6 sulfatoxymelatonin; Estradiol; Follicle stimulating hormone; Melatonin; Menopause; Obesity

Indexed keywords

ESTRADIOL; FOLLITROPIN; MELATONIN; 6-SULFATOXYMELATONIN;

ADULT; ANXIETY; APPETITE DISORDER; ARTICLE; BODY MASS; CONTROLLED STUDY; DEPRESSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLICULAR PHASE; HORMONE URINE LEVEL; HUMAN; MAJOR CLINICAL STUDY; NUTRITIONAL STATUS; OBESITY; POSTMENOPAUSE; VISUAL ANALOG SCALE; WEIGHT GAIN; ANALOGS AND DERIVATIVES; BLOOD; MIDDLE AGED; URINE;

ADULT; BODY MASS INDEX; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; MELATONIN; MIDDLE AGED; OVERWEIGHT; POSTMENOPAUSE;

EID: 84920516911     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16011030     Document Type: Article

References (64)

1. Freeman, E.W.; Sammel, M.D.; Lin, H.; Nelson, D.B. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch. Gen. Psychiatry 2006, 63, 375–382.
2. Frey, B.N.; Lord, C.; Soares, C.N. Depression during menopausal transition, a review of treatment strategies and pathophysiological correlates. Menopause Int. 2008, 14, 123–128.
3. Freeman, E.W. Associations of depression with the transition to menopause. Menopause 2010, 17, 823–827.
4. Everson-Rose, S.A.; Lewis, T.T.; Karavolos, K.; Dugan, S.A.; Wesley, D.; Powell, L.H. Depressive symptoms and increased visceral fat in middle-aged women. Psychosom. Med. 2009, 71, 410–416.
5. Murabito, J.M.; Massaro, J.M.; Clifford, B.; Hoffmann, U.; Fox, C.S. Depressive symptoms are associated with visceral adiposity in a community-based sample of middle-aged women and men. Obesity 2013, 21, 1713–1719.
6. Wiltink, J.; Michal, M.; Wild, P.S.; Zwiener, I.; Blettner, M.; Münzel, T.; Schulz, A.; Kirschner, Y.; Beutel, M.E. Associations between depression and different measures of obesity (BMI, WC, WHtR, WHR). BMC Psychiatry 2013, 13, 223.
7. Chang, C.J.; Wu, C.H.; Yao, W.J.; Yang, Y.C.; Wu, J.S.; Lu, F.H. Relationships of age, menopause and central obesity on cardiovascular disease risk factors in Chinese women. Int. J. Obes. Relat. Metab. Disord. 2000, 24, 1699–1704.
8. Dasgupta, S.; Salman, M.; Lokesh, S.; Xaviour, D.; Saheb, S.Y.; Prasad, B.V.; Sarkar, B. Menopause versus aging. The predictor of obesity and metabolic aberrations among menopausal women of Karnataka, South India. J. Midlife Health 2012, 3, 24–30.
9. Zedler, B.; von Lengerke, T.; Emeny, R.; Heier, M.; Lacruz, M.E.; Ladwig, K.H. Obesity and symptoms of depression and anxiety in pre- and post-menopausal women, a comparison of different obesity indicators. Psychother. Psychosom. Med. Psychol. 2014, 64, 128–135.
10. Asarian, L.; Geary, N. Cyclic estradiol treatment normalizes body weight and restores physiological patterns of spontaneous feeding and sexual receptivity in ovariectomized rats. Horm. Behav. 2002, 42, 461–471.
11. Yu, Z.; Geary, N.; Corwin, R.L. Ovarian hormones inhibit fat intake under binge-type conditions in ovariectomized rats. Physiol. Behav. 2008, 95, 501–507.
12. Benmansour, S.; Privratsky, A.A.; Adeniji, O.S.; Frazer, A. Signaling mechanisms involved in the acute effects of estradiol on 5-HT clearance. Int. J. Neuropsychopharmacol. 2014, 17, 765–777.
13. Butera, P.C.; Bradway, D.M.; Cataldo, N.J. Modulation of the satiety effect of cholecystokinin by estradiol. Physiol. Behav. 1993, 53, 1235–1238.
14. Geary, N. The effect of estrogen on appetite. Medscape Women’s Health 1998, 3, 3.
15. Asarian, L.; Geary, N. Modulation of appetite by gonadal steroid hormones. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2006, 361, 1251–1263.
16. Hutson, W.R.; Roehrkasse, R.L.; Wald, A. Influence of gender and menopause on gastric emptying and motility. Gastroenterology 1989, 96, 11–17.
17. Bond, E.F.; Heitkemper, M.M.; Bailey, S.L. Estrogen suppresses gastric motility response to thyrotropin-releasing hormone and stress in awake rats. Res. Nurs. Health 1998, 21, 221–228.
18. Amure, B.O.; Omole, A.A. Sex hormones, and acid gastric secretion induced with carbachol, histamine, and gastrin. Gut 1970, 11, 641–645.
19. Tuo, B.; Wen, G.; Wei, J.; Liu, X.; Wang, X.; Zhang, Y.; Wu, H.; Dong, X.; Chow, J.Y.; Vallon, V.; Dong H. Estrogen regulation of duodenal bicarbonate secretion and sex-specific protection of human duodenum. Gastroenterology 2011, 141, 854–863.
20. De Villiers, T.J.; Gass, M.L.; Haines, C.J.; Hall, J.E.; Lobo, R.A.; Pierroz, D.D.; Rees, M. Global Consensus Statement on menopausal hormone therapy. Climacteric 2013, 16, 203–204.
21. Rossouw, J.E.; Prentice, R.L.; Manson, J.E.; Wu, L.; Barad, D.; Barnabei, V.M.; Ko, M.; LaCroix, A.Z.; Margoliş K.L.; Stefanick, M.L. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007, 297, 1465–1477.
22. Archer, D.F.; Oger, E. Estrogen and progestogen effect on venous thromboembolism in menopausal women. Climacteric 2012, 15, 235–240.
23. Speroff, L. Transdermal hormone therapy and the risk of stroke and venous thrombosis. Climacteric 2010, 13, 429–432.
24. Lobo, R.A. Menopause and stroke and the effects of hormonal therapy. Climacteric 2007, 10, 27–31.
25. Antoine, C.; Ameye, L.; Paesmans, M.; Rozenberg, S. Treatment of climacteric symptoms in breast cancer patients: A retrospective study from a medication databank. Maturitas 2014, 78, 228–232.
26. De Villiers, T.J.; Pines, A.; Panay, N.; Gambacciani, M.; Archer, D.F.; Baber, R.J.; Davis SR.; Gompel, A.A.; Henderson, V.W.; Langer, R. et al. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 2013, 16, 316–337.
27. North American Menopause Society. The 2012 hormone therapy position statement of The North American Menopause Society. Menopause 2012, 19, 257–271.
28. Voelker, R. FDA expands warning on diet products. JAMA 2009, 301, 1646.
29. Brambilla, F.; Fraschini, F.; Esposti, G.; Bossolo, P.A.; Marelli, G.; Ferrari, E. Melatonin circadian rhythm in anorexia nervosa and obesity. Psychiatry Res. 1988, 23, 267–276.
30. Ferrari, E.; Foppa, S.; Bossolo, P.A.; Comis, S.; Esposti, G.; Licini, V.; Fraschini, F.; Brambilla, F. Melatonin and pituitary-gonadal function in disorders of eating behavior. J. Pineal Res. 1989, 7, 115–124.
31. Lima, F.B.; Machado, U.F.; Bartol, I.; Seraphim, P.M.; Sumida, D.H.; Moraes, S.M.; Hell, N.S.; Okamoto, M.M.; Saad, M.J.; Carvalho, C.R. et al. Pinealectomy causes glucose intolerance and decreases adipose cell responsiveness to insulin in rats. Am. J. Physiol. 1998, 275, E934–E941.
32. Picinato, M.C.; Haber, E.P.; Carpinelli, A.R.; Cipolla-Neto, J. Daily rhythm of glucose-induced insulin secretion by isolated islets from intact and pinealectomized rat. J. Pineal Res. 2002, 33, 172–177.
33. Rasmussen, D.D.; Boldt, B.M.; Wilkinson, C.W.; Yellon, S.M.; Matsumoto, A.M. Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels. Endocrinology 1999, 140, 1009–1012.
34. Alonso-Vale, M.I.; Andreotti, S.; Peres, S.B.; Anhê, G.F.; das Neves Borges-Silva, C.; Neto, J.C.; Lima, F.B. Melatonin enhances leptin expression by rat adipocytes in the presence of insulin. J. Appl. Physiol. 2005, 98, 1037–1043.
35. Ríos-Lugo, M.J.; Cano, P.; Jiménez-Ortega, V.; Fernández-Mateos, M.P.; Scacchi, P.A.; Cardinali, D.P.; Esquifino, A.I. Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat-fed rats. J. Pineal Res. 2010, 49, 342–348.
36. Agil, A.; Navarro-Alarcón, M.; Ruiz, R.; Abuhamadah, S.; El-Mir, M.Y.; Vázquez, G.F. Beneficial effects of melatonin on obesity and lipid profile in young Zucker diabetic fatty rats. J. Pineal Res. 2011, 50, 207–212.
37. Favero, G.; Lonati, C.; Giugno, L.; Castrezzati, S.; Rodella, L.F.; Rezzani, R. Obesity-related dysfunction of the aorta and prevention by melatonin treatment in ob/ob mice. Acta Histochem. 2013, 115, 783–788.
38. Zanuto, R.; Siqueira-Filho, M.A.; Caperuto, L.C.; Bacurau, R.F.; Hirata, E.; Peliciari-Garcia, R.A.; do Amaral, F.G.; Marçal, A.C.; Ribeiro, L.M.; Camporez, J.P. et al. Melatonin improves insulin sensitivity independently of weight loss in old obese rats. J. Pineal Res. 2013, 55, 156–165.
39. Cardinali, D.P.; Cano, P.; Jiménez-Ortega, V.; Esquifino A.I. Melatonin and the metabolic syndrome, physiopathologic and therapeutical implications. Neuroendocrinology 2011, 93, 133–142.
40. Walecka-Kapica, E.; Klupińska, G.; Chojnacki, J.; Tomaszewska-Warda, K.; Błońska, A.; Chojnacki, C. The effect of melatonin on the quality of sleep and nutritional status in postmenopausam women. Menopausal Rev. 2014, in press.
41. Cipolla-Neto, J.; Amaral, F.G.; Afeche, S.C.; Tan, D.X.; Reiter, R.J. Melatonin, energy metabolism, and obesity, a review. J. Pineal Res. 2014, 56, 371–381.
42. Kennaway, D.J.; Lushington, K.; Dawson, D.; Lack, L.; van den Heuvel, C.; Rogers, N. Urinary 6-sulfatoxymelatonin excretion and aging, new results and a critical review of the literature. J. Pineal Res. 1999, 27, 210–220.
43. Toffol, E.; Kalleinen, N.; Haukka, J.; Vakkuri, O.; Partonen, T.; Polo-Kantola, P. Melatonin in perimenopausal and postmenopausal women, associations with mood, sleep, climacteric symptoms, and quality of life. Menopause 2014, 21, 493–500.
44. Reiter, R.J.; Tan, D.X.; Fuentes-Broto, L. Melatonin, a multitasking molecule. Prog. Brain Res. 2010, 181, 127–151.
45. Bódis, J.; Koppán, M.; Kornya, L.; Tinneberg, H.R.; Török, A. Influence of melatonin on basal and gonadotropin-stimulated progesterone and estradiol secretion of cultured human granulosa cells and in the superfused granulosa cell system. Gynecol. Obstet. Investig. 2001, 52, 198–202.
46. Luboshitzky, R.; Herer, P.; Shen-Orr, Z. Cyproterone acetate-ethinyl estradiol treatment alters urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women. Neuro Endocrinol. Lett. 2002, 23, 309–313.
47. Gruber, D.M.; Schneeberger, C.; Laml, T.; Sator, M.O.; Huber, J.C. 6-sulfatoxymelatonin in women with secondary amenorrhea. Wien. Klin. Wochenschr. 1997, 109, 750–752.
48. Okatani, Y.; Morioka, N.; Wakatsuki, A. Changes in nocturnal melatonin secretion in perimenopausal women, correlation with endogenous estrogen concentrations. J. Pineal Res. 2000, 28, 111–118.
49. Vakkuri, O.; Kivelä, A.; Leppäluoto, J.; Valtonen, M.; Kauppila, A. Decrease in melatonin precedes follicle-stimulating hormone increase during perimenopause. Eur. J. Endocrinol. 1996, 135, 188–192.
50. Blaicher, W.; Imhof, M.H.; Gruber, D.M.; Schneeberger, C.; Sator, M.O.; Huber, J.C. Endocrinological disorders: Focusing on melatonin’s interactions. Gynecol. Obstet. Investig. 1999, 48, 179–182.
51. Sanchez-Mateos, S.; Alonso-Gonzalez, C.; Gonzalez, A.; Martinez-Campa, CM.; Mediavilla, M.D.; Cos, S.; Sanchez-Barcelo, E.J. Melatonin and estradiol effects on food intake, body weight, and leptin in ovariectomized rats. Maturitas 2007, 58, 91–101.
52. Sartori, C.; Dessen, P.; Mathieu, C.; Monney, A.; Bloch, J.; Nicod, P.; Scherrer, U.; Duplain, H. Melatonin improves glucose homeostasis and endothelial vascular function in high-fat diet-fed insulin-resistant mice. Endocrinology 2009, 150, 5311–5317.
53. Nduhirabandi, F.; Du Toit, E.F.; Blackhurst, D.; Marais, D.; Lochner, A. Chronic melatonin consumption prevents obesity-related metabolic abnormalities and protects the heart against myocardial ischemia and reperfusion injury in a prediabetic model of diet-induced obesity. J. Pineal Res. 2011, 50, 171–182.
54. Srinivasan, V.; Ohta, Y.; Espino, J.; Pariente, J.A.; Rodriguez, A.B.; Mohamed, M.; Zakaria, R. Metabolic syndrome, its pathophysiology and the role of melatonin. Recent Pat. Endocr. Metab. Immune Drug Discov. 2013, 7, 11–25.
55. Wolden-Hanson, T.; Mitton, D.R.; McCants, R.L.; Yellon, S.M.; Wilkinson, C.W.; Matsumoto, A.M.; Rasmussen, D.D. Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology 2000, 141, 487–497.
56. Prunet-Marcassus, B.; Desbazeille, M. Bros, A.; Louche, K.; Delagrange, P.; Renard, P.; Casteilla, L.; Pénicaud, L. Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. Endocrinology 2003, 144, 5347–5352.
57. Hussein, M.R.; Ahmed, O.G.; Hassan, A.F.; Ahmed, M.A. Intake of melatonin is associated with amelioration of physiological changes, both metabolic and morphological pathologies associated with obesity, an animal model. Int. J. Exp. Pathol. 2007, 88, 19–29.
58. Reiter, R.J.; Tan, D.X.; Korkmaz, A.; Ma, S. Obesity and metabolic syndrome, association with chronodisruption, sleep deprivation, and melatonin suppression. Ann. Med. 2012, 44, 564–577.
59. Korkmaz, A.; Topal, T.; Tan, D.X.; Reiter, R.J. Role of melatonin in metabolic regulation. Rev. Endocr. Metab. Disord. 2009, 10, 261–270.
60. Blaicher, W.; Speck, E.; Imhof, M.H.; Gruber, D.M.; Schneeberger, C.; Sator, M.O.; Huber, J.C. Melatonin in postmenopausal females. Arch. Gynecol. Obstet. 2000, 263, 116–118.
61. Nduhirabandi, F.; du Toit, E.F.; Lochner, A. Melatonin and the metabolic syndrome: A tool for effective therapy in obesity-associated abnormalities? Acta Physiol. (Oxf.) 2012, 205, 209–223.
62. Rastmanesh, R.; de Bruin, P.F. Potential of melatonin for the treatment or prevention of obesity, an urgent need to include weight reduction as a secondary outcome in clinical trials of melatonin in obese patients with sleep disorders. Contemp. Clin. Trials 2012, 33, 574–575.
63. Kato, K.; Murai, I.; Asai, S.; Takahashi, Y.; Matsuno, Y.; Komuro, S.; Kurosaka, H.; Iwasaki, A.; Ishikawa, K.; Arakawa, Y. Central nervous system action of melatonin on gastric acid and pepsin secretion in pylorus-ligated rats. Neuroreport 1998, 9, 2447–2450.
64. Sjöblom, M.; Flemström, G. Melatonin in the duodenal lumen is a potent stimulant of mucosal bicarbonate secretion. J. Pineal Res. 2003, 34, 288–293.